Advertisements

Cadila Healthcare Q4 PAT seen up 39.7% YoY to Rs. 538.4 cr: Edelweiss

Cadila Healthcare Q4 PAT seen up 39.7% YoY to Rs. 538.4 cr: Edelweiss.....»»

Category: topSource: moneycontrolApr 16th, 2018

Cadila Healthcare Q4 PAT seen up 36.5% YoY to Rs. 530 cr: HDFC Securities

Cadila Healthcare Q4 PAT seen up 36.5% YoY to Rs. 530 cr: HDFC Securities.....»»

Category: topSource: moneycontrolApr 20th, 2018

Cadila Healthcare stock: Analysts see 20% compounded growth in US sales

Cadila Healthcare stock: Analysts see 20% compounded growth in US sales.....»»

Category: featuresSource: business-standardMar 30th, 2018

Top buzzing midcap stocks to trade on March 26

Top buzzing midcap stocks to trade on March 26.....»»

Category: topSource: moneycontrolMar 26th, 2018

Cadila Healthcare gains 4% on USFDA nod for Metoprolol Succinate tablets

Cadila Healthcare gains 4% on USFDA nod for Metoprolol Succinate tablets.....»»

Category: topSource: business-standardMar 26th, 2018

SBI, Tata Motors, Bosch among 60 stocks from BSE500 index hit 52-week lows

SBI, Tata Motors, Bosch among 60 stocks from BSE500 index hit 52-week lows.....»»

Category: topSource: business-standardMar 23rd, 2018

Cadila Healthcare up 2% on USFDA approval to market Tizanidine tablets

Cadila Healthcare up 2% on USFDA approval to market Tizanidine tablets.....»»

Category: topSource: moneycontrolMar 13th, 2018

Hold Cadila Healthcare, says Rajat Bose

Hold Cadila Healthcare, says Rajat Bose.....»»

Category: topSource: moneycontrolFeb 22nd, 2018

Stay with Cadila Healthcare: Vijay Chopra

Stay with Cadila Healthcare: Vijay Chopra.....»»

Category: topSource: moneycontrolFeb 22nd, 2018

Accumulate Cadila Healthcare; target of Rs 436: KR Choksey

Accumulate Cadila Healthcare; target of Rs 436: KR Choksey.....»»

Category: topSource: moneycontrolFeb 14th, 2018

Cadila Healthcare Q3 beats estimates, profit grows 68% despite significant rise in tax cost - Moneycontrol.com

Cadila Healthcare Q3 beats estimates, profit grows 68% despite significant rise in tax cost - Moneycontrol.com.....»»

Category: topSource: googlenewsFeb 8th, 2018

Cadila Healthcare Q3 beats estimates, profit grows 68% despite significant rise in tax cost

Cadila Healthcare Q3 beats estimates, profit grows 68% despite significant rise in tax cost.....»»

Category: topSource: moneycontrolFeb 8th, 2018

ABB, ACC, BHEL, SAIL results on Thursday

ABB, ACC, BHEL, SAIL results on Thursday.....»»

Category: marketsSource: thehindubusinesslineFeb 7th, 2018

Cadila Healthcare turns focus on vaccines and biosimilars

Cadila Healthcare turns focus on vaccines and biosimilars.....»»

Category: featuresSource: business-standardJan 24th, 2018

Pharma weekly wrap: Pharma stocks extend loses ahead of Q3 results

Pharma weekly wrap: Pharma stocks extend loses ahead of Q3 results.....»»

Category: topSource: moneycontrolJan 20th, 2018

Pharma shares gain; Sun Pharma hits seven-month high - Business Standard

Pharma shares gain; Sun Pharma hits seven-month high - Business Standard.....»»

Category: topSource: googlenewsJan 8th, 2018

Pharma shares gain; Sun Pharma hits seven-month high

Pharma shares gain; Sun Pharma hits seven-month high.....»»

Category: topSource: business-standardJan 8th, 2018

Glenmark Pharmaceutical launches biosimilar of Adalimumab in India

Glenmark Pharmaceutical launches biosimilar of Adalimumab in India.....»»

Category: topSource: moneycontrolJan 4th, 2018

Healthy trend: Indian pharma firms see rise in USFDA drug approvals in FY18

Healthy trend: Indian pharma firms see rise in USFDA drug approvals in FY18.....»»

Category: topSource: business-standardJan 2nd, 2018

Zydus Pharmaceuticals receives USFDA nod to market OCD treatment drug

Zydus Pharmaceuticals receives USFDA nod to market OCD treatment drug.....»»

Category: economySource: business-standardDec 29th, 2017

Cadila Healthcare rises over 2% as Zydus receives USFDA nod for antiobsessional drug

Cadila Healthcare rises over 2% as Zydus receives USFDA nod for antiobsessional drug.....»»

Category: topSource: moneycontrolDec 29th, 2017